CHE Chemed Corp

Price (delayed)

$466.77

Market cap

$6.99B

P/E Ratio

26.92

Dividend/share

$1.44

EPS

$17.34

Enterprise value

$7.24B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of ...

Highlights
The price to earnings (P/E) is 12% lower than the 5-year quarterly average of 30.3
CHE's gross profit is up by 7% year-on-year
The debt has soared by 96% year-on-year but it is down by 17% since the previous quarter
Chemed's equity has decreased by 28% YoY but it has increased by 7% from the previous quarter
Chemed's quick ratio has plunged by 56% YoY and by 14% from the previous quarter
The net income has declined by 19% year-on-year

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
14.97M
Market cap
$6.99B
Enterprise value
$7.24B
Valuations
Price to earnings (P/E)
26.92
Price to book (P/B)
10.49
Price to sales (P/S)
3.26
EV/EBIT
20.46
EV/EBITDA
17.52
EV/Sales
3.38
Earnings
Revenue
$2.14B
EBIT
$353.65M
EBITDA
$413.13M
Free cash flow
$249.34M
Per share
EPS
$17.34
Free cash flow per share
$16.64
Book value per share
$44.48
Revenue per share
$142.96
TBVPS
$41.35
Balance sheet
Total assets
$1.31B
Total liabilities
$639.05M
Debt
$267.98M
Equity
$666.71M
Working capital
-$94.9M
Liquidity
Debt to equity
0.4
Current ratio
0.66
Quick ratio
0.48
Net debt/EBITDA
0.6
Margins
EBITDA margin
19.3%
Gross margin
36.3%
Net margin
12.5%
Operating margin
16.4%
Efficiency
Return on assets
20%
Return on equity
36.4%
Return on invested capital
65.6%
Return on capital employed
34.5%
Return on sales
16.5%
Dividend
Dividend yield
0.31%
DPS
$1.44
Payout ratio
8.3%

CHE stock price

How has the Chemed stock price performed over time
Intraday
0.59%
1 week
3.29%
1 month
-5.62%
1 year
-3.25%
YTD
-11.77%
QTD
-7.85%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.14B
Gross profit
$776.91M
Operating income
$351.97M
Net income
$267.32M
Gross margin
36.3%
Net margin
12.5%
The net margin is down by 20% year-on-year
The net income has declined by 19% year-on-year
The operating margin has decreased by 12% YoY but it has increased by 2.5% QoQ
Chemed's operating income has decreased by 10% YoY but it has increased by 2.6% from the previous quarter

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
26.92
P/B
10.49
P/S
3.26
EV/EBIT
20.46
EV/EBITDA
17.52
EV/Sales
3.38
The EPS has decreased by 16% YoY
The price to earnings (P/E) is 12% lower than the 5-year quarterly average of 30.3
Chemed's equity has decreased by 28% YoY but it has increased by 7% from the previous quarter
The P/B is 15% more than the 5-year quarterly average of 9.1
CHE's P/S is 10% below its last 4 quarters average of 3.6
The revenue rose by 2.5% year-on-year

Efficiency

How efficient is Chemed business performance
The company's return on invested capital fell by 42% YoY and by 9% QoQ
The ROA has declined by 16% year-on-year but it rose by 2.6% since the previous quarter
The ROS has decreased by 16% YoY
The ROE has grown by 9% from the previous quarter but it has contracted by 6% YoY

Dividends

What is CHE's dividend history
DPS
$1.44
Dividend yield
0.31%
Payout ratio
8.3%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's total assets is 104% higher than its total liabilities
Chemed's quick ratio has plunged by 56% YoY and by 14% from the previous quarter
CHE's current ratio is down by 45% YoY and by 13% from the previous quarter
The debt is 60% smaller than the equity
CHE's debt to equity has surged by 167% year-on-year but it is down by 23% since the previous quarter
The debt has soared by 96% year-on-year but it is down by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.